Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension

F. Kato, N. Tanabe, H. Kasai, A. Sekine, T. Takeuchi, T. Urushibara, R. Nishimura, R. Suda, T. Jujo, T. Sugiura, A. Shigeta, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba-shi, Japan)

Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Session: Pulmonary circulation: clinical end-points and clinical physiology
Session type: Thematic Poster Session
Number: 3935
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Kato, N. Tanabe, H. Kasai, A. Sekine, T. Takeuchi, T. Urushibara, R. Nishimura, R. Suda, T. Jujo, T. Sugiura, A. Shigeta, S. Sakao, Y. Kasahara, K. Tatsumi (Chiba-shi, Japan). Plasma high fibrinogen and low plasminogen levels predict poor prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension. Eur Respir J 2012; 40: Suppl. 56, 3935

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients
Source: Eur Respir J, 56 (4) 2001811; 10.1183/13993003.01811-2020
Year: 2020



The importance of high plasma levels of factor VIIIc in the severity of pulmonary thromboembolism
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001

Elevated pulmonary vascular resistance predicts mortality in COPD patients
Source: Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Year: 2021



Elevated D-dimer and low ferritin may help predict pulmonary emboli in mild-moderate COVID-19
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021


Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 57 (4) 2003201; 10.1183/13993003.03201-2020
Year: 2021



Higher serum C-reactive protein levels predict a worse outcome in patients with acute cardiogenic pulmonary edema treated with continuous positive airway pressure
Source: Eur Respir J 2004; 24: Suppl. 48, 92s
Year: 2004

Relationship between circulating thrombomodulin levels and latent progression of atherosclerosis in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


Circulating endothelial cell levels decrease after vasodilator therapy and are a biomarker of clinical worsening in refractory pulmonary hypertension in children
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012

Predictors of poor outcome in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012


Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019


Platelet function in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009

Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Relationship between severity of disease and D-dimer levels which were measured with two different methods in pulmonary embolism patients
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Plasma fibrinogen in patients with chronic obstructive pulmonary disease (COPD) with or without secondary erythrocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 586s
Year: 2005

Bosentan improves 6-minutes-walk-test in patients with inoperable chronic thrombo-embolic pulmonary hypertension (iCTEPH)
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005

Factors associated with survival in patients with not-operated chronic thromboembolic pulmonary hypertension (CTEPH) in the modern management era
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009

Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005